Neil Herskowitz Avenue Therapeutics, Inc. (ATXI) insider trading activity

ATXI Quotes by TradingView

Neil Herskowitz is Director of AVENUE THERAPEUTICS, INC.. Currently has a direct ownership of 97 shares of ATXI, which is worth approximately $129. The most recent transaction as insider was on Dec 02, 2024, when has been sold 23 shares (Common Stock, par value $0.0001) at a price of $2.0 per share, resulting in proceeds of $46. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 97
99.95% 3M change
99.95% 12M change
Total Value Held $129

Neil Herskowitz Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 02 2024
SELL
Open market or private sale
$46 $2.0 p/Share
23 Reduced 19.17%
97 Common Stock, par valu...
Dec 17 2021
BUY
Grant, award, or other acquisition
-
69,020 Added 27.31%
183,744 Common Stock
May 06 2021
BUY
Open market or private purchase
$9,975 $3.99 p/Share
2,500 Added 1.82%
134,724 Common Stock

Also insider at

CKPT
Checkpoint Therapeutics, Inc. Healthcare
Director
DERM
Journey Medical Corp Healthcare
Director
MBIO
MUSTANG BIO, INC. Healthcare
Director
NH

Neil Herskowitz

Director
Scottsdale, AZ

Track Institutional and Insider Activities on ATXI

Follow AVENUE THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATXI shares.

Notify only if

Insider Trading

Get notified when an Avenue Therapeutics, Inc. insider buys or sells ATXI shares.

Notify only if

News

Receive news related to AVENUE THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ATXI